Nexpoint Asset Management’s Tourmaline Bio TRML Stock Holding History

Nexpoint Asset Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-455,360	Closed	-$21.8M	–	121
2025 Q3	$21.8M	Buy	+455,360	New	+$12.6M	1.89%	15

Nexpoint Asset Management's TRML Position: Q4 2025 in Review

Nexpoint Asset Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 455,360 shares — an estimated $21.8M sold.

Nexpoint Asset Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $21.8M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Nexpoint Asset Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Nexpoint Asset Management sold 455,360 Tourmaline Bio shares in Q4 2025, an estimated $21.8M.
Nexpoint Asset Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Nexpoint Asset Management's Tourmaline Bio position peaked at $21.8M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Nexpoint Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.